Generic name: ibuprofen lysine
Dosage form: injection
This dosage information does not include all the information needed to use NeoProfen safely and effectively. See full prescribing information for NeoProfen.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
A course of therapy is three doses of NeoProfen administered intravenously (administration via an umbilical arterial line has not been evaluated). An initial dose of 10 mg per kilogram is followed by two doses of 5 mg per kilogram each, after 24 and 48 hours. All doses should be based on birth weight. If anuria or marked oliguria (urinary output <0.6 mL/kg/hr) is evident at the scheduled time of the second or third dose of NeoProfen, no additional dosage should be given until laboratory studies indicate that renal function has returned to normal. If the ductus arteriosus closes or is significantly reduced in size after completion of the first course of NeoProfen, no further doses are necessary. If during continued medical management the ductus arteriosus fails to close or reopens, then a second course of NeoProfen, alternative pharmacological therapy, or surgery may be necessary.
Directions for Use
For intravenous administration only. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Do not use NeoProfen if particulate matter is observed.
After the first withdrawal from the inert vial, any solution remaining must be discarded because NeoProfen contains no preservative.
For administration, NeoProfen should be diluted to an appropriate volume with dextrose or saline. NeoProfen should be prepared for infusion and administered within 30 minutes of preparation and infused continuously over a period of 15 minutes. The drug should be administered via the IV port that is nearest the insertion site. After the first withdrawal from the inert vial, any solution remaining must be discarded because NeoProfen contains no preservative.
Since NeoProfen is potentially irritating to tissues, it should be administered carefully to avoid extravasation.
NeoProfen should not be simultaneously administered in the same intravenous line with Total Parenteral Nutrition (TPN). If necessary, TPN should be interrupted for a 15-minute period prior to and after drug administration. Line patency should be maintained by using dextrose or saline.
- NeoProfen Side Effects
- NeoProfen Drug Interactions
- Advil (ibuprofen) consumer information
- Caldolor (ibuprofen) intravenous infusion dosage information
- Caldolor (ibuprofen) consumer information
- IBU Tablets (ibuprofen) tablet, film coated dosage information
- Ibuprofen dosage information
- Ibuprofen consumer information
- Motrin (ibuprofen) suspension dosage information
- Motrin (ibuprofen) consumer information
- Motrin IB (ibuprofen) tablet, coated dosage information